Estrigenix Therapeutics
Latest round
- Seed
Last raised
- Jul 2026
Total raised
- $1.1M
Investors
- 2
About Estrigenix Therapeutics
, also known as Estrigenix, operates as a pharmaceutical company that offers drugs for menopausal women. The company was formed as a spin-out of the collaborative research of three Milwaukee area university scientists: William Donaldson (CEO), Karyn Frick (CSO), and Daniel Sem. In July 2026, Estrigenix Therapeutics, Inc. Estrigenix offers novel therapeutics and pharmaceuticals that address the pressing medical needs of post-menopausal women by treating hot flashes and dementia, which commonly afflict women around the age of 50 during menopause. The company develops next-generation therapeutics, mainly estrogen-based products, with the help of patents like substituted (4-hydroxyphenyl)cyclohexane compounds and substituted (4-hydroxyphenyl)cycloalkane and (4-hydroxyphenyl)cycloalkene compounds. The company conducts estrogen-based research and undergoes clinical trials with its lead drug candidate, EGX358.
Who invested in Estrigenix Therapeutics
2 investors across 2 rounds
See all investors in Estrigenix Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Estrigenix Therapeutics
Who invested in Estrigenix Therapeutics?
Estrigenix Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Estrigenix Therapeutics raised?
Estrigenix Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Estrigenix Therapeutics last raise money?
Estrigenix Therapeutics's most recent round on record is a Seed, in Jul 2026.
What does Estrigenix Therapeutics do?
, also known as Estrigenix, operates as a pharmaceutical company that offers drugs for menopausal women.
Where is Estrigenix Therapeutics headquartered?
Estrigenix Therapeutics is headquartered in Milwaukee, US.
Which VCs invest in companies like Estrigenix Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Estrigenix Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Estrigenix Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.